|
NO |
Sesi |
Keyword |
|
|
Kode |
Judul |
||
|
151 |
Bayside Auditorium B |
Estimating the Effect of Disruptive Technologies and Policies in the US Healthcare Market |
Economics evaluations and methods; Private sector in universal health coverage era; |
|
152 |
Bayside Auditorium A |
The Effect of Migration on Health, Health Insurance, and Health Behaviors |
Non communicable diseases, tobacco and nutrition; Equity and equality |
|
153 |
Bayside Terrace |
Affordable Care Act Policies to Expand Coverage: Evidence Public Sector, Employer-Sponsored, and Individual and Small Group Markets |
Health care policy; Health care reform; Universal health coverage |
|
154 |
Bayside 103 |
An Evolutionary Tale of Five Preference-Weighted Health State Utility Measures |
Economic evaluation and methods |
|
155 |
Bayside 104 |
Advances in Discrete Choice Experiments among National Policy Makers: Eliciting Equity-Efficiency Preferences in Health |
Discrete Choice Experiments; Health providers and patient choice |
|
156 |
Bayside 204A |
Methodological Challenges for Estimating Health Service Delivery Costs in Low-Income Settings |
Service delivery, access and healthcare utilization; Economics evaluations and methods; Costs of care |
|
157 |
Bayside 204B |
Physician-Patient Interaction in the Pharmaceutical Market |
Pharmaceutical and subtances; Patient behavior and behavioral economics |
|
158 |
Bayside 102 |
Financial Incentives in Health: Evidence from India’s Janani Suraksha Yojana |
Health financing; Quality of care; Service delivery, access and healthcare utilization; Maternal and child health |
|
159 |
Bayside 105 |
Does Price Discrimination have a Place in Pharmaceutical Pricing in Developing Countries? |
Pharmaceutical and subtances; Economic evaluations and methods |
|
160 |
Bayside 109 |
Economics of Cannabis Use |
Pharmaceutical and subtances; Economic evaluations and methods |
|
161 |
Bayside 201 |
Pricing, Promotion and Obesity: Implications for Taxation and Regulatory Policies |
Non communicable diseases, tobacco and nutrition; |
|
162 |
Bayside 202 |
The Costs and Provision of ART Care Across Three Developing Countries |
Quality of care; Costs of care |
|
163 |
Bayside 203 |
Analysing Unexplained Variations in Performance to Increase the Efficiency of Health Care: Case Studies from the ECHO Project |
Economic evaluations and methods; Quality of care |
|
164 |
Bayside 106 |
Measuring Universal Health Coverage: Health Service Utilization and the Financial Burden of Health Payments in Asia |
Universal health coverage; Service delivery, access and health care utilization; Health financing |
|
165 |
Bayside 101 |
India: Quality, Accountability, and Financing Reform |
Quality of care |
|
166 |
Bayside Auditorium B |
The Origins of Health Economics: Some Reflections on Early Contributors to Health Economic Thought |
Economics evaluations and methods; Equity and equility |
|
167 |
Bayside Auditorium A |
Health Equity and Financial Protection in Asia Impacts of Health Insurance Reform in Four Countries |
Equity and equality; Health financing; Maternal and child health; Universal health coverage |
|
168 |
Bayside Terrace |
Use of Discrete Choice Experiments to Elicit End-of-Life Health Care Attitudes and Preferences |
Discrete Choice Experiments |
|
169 |
Bayside 103 |
Networks in Health Economics |
Economic evaluations and methods; Private sector in universal health coverage era; Health policy |
|
170 |
Bayside 104 |
Breaking the Addiction to Adoption in Health Economics: Perspectives from Australia, Scotland, Canada and England |
Quality of care; Health care reform |
|
171 |
Bayside 204A |
Guidelines for Choosing the Appropriate Technique for Multi-Criteria Decision Analysis in Health Care |
Health policy |
|
172 |
Bayside 204B |
Physician Incentives: Evidence from East Asia |
Health professions; Patient behavior and behavioral economics |
|
173 |
Bayside 102 |
The Broader Economic Impact of Vaccination in Low and Middle Income Countries: Fiscal Space Related Issues |
Communicable diseases, HIV/AIDS, and vaccines; Health financing |
|
174 |
Bayside 105 |
Coverage, Value, and Sustainability of Micro Health Insurance on the Indian Subcontinent |
Universal health coverage; Service delivery, access and health care utilization |
|
175 |
Bayside 109 |
Incentives for Safe Sex: Evaluating Economic Incentives as a Prevention Strategy for HIV and other Sexually Transmitted Infections (STIs) |
Communicable diseases, HIV/AIDS, and vaccines; Economics evaluations and methods |
|
176 |
Bayside 201 |
Dental Health Economics |
Service delivery, access and healthcare utilization; Economics evaluations and methods; Health financing |
|
177 |
Bayside 202 |
Efficiency Measurement Incorporating Quality: Exploring New Methodological Approaches |
Quality of care; Health care reform |
|
178 |
Bayside 203 |
Analytical Advancements in Measuring Development Assistance for Health |
Health policy; Health financing |
|
179 |
Bayside 106 |
Risky Behaviors and Human Capital |
Impact of health status; Mental health and elderly health issues; Pharmaceutical and subtances; |
|
180 |
Bayside 101 |
What Can Myanmar Learn from its Neighbours as it Starts its Journey to Achieve Universal Health Coverage? |
Universalh health coverage; Health financing |
|
181 |
Bayside Auditorium B |
What is the Impact of Health Status |
Impact of health status |
|
182 |
Bayside Auditorium A |
What Affects Access to Care |
Service delivery, access, and health care utilization; Patient behavior and behavioral economics; Equity and equality |
|
183 |
Bayside Terrace |
Economic Evaluation of Screening |
Economic evaluations and methods; Costs of care |
|
184 |
Bayside 103 |
Health Status & Methodology |
Impact of health status; Mental health and elderly health issues |
|
185 |
Bayside 104 |
Access to Care |
Service delivery, access and health care utilization; Health providers and patient choice; Universal Health Coverage; Equity and equality |
|
186 |
Bayside 204A |
Allied and Informal Health Providers |
Health professions; Health providers and patient choices; Quality of care; Maternal and child health |
|
187 |
Bayside 204B |
Impact of Technology |
Quality of care |
|
188 |
Bayside 102 |
Economic Evaluation of Programmes II |
Economic evaluations and methods; Costs of care |
|
189 |
Bayside 105 |
Equity & Inequality Issues |
Equity and equility; Universal health coverage |
|
190 |
Bayside 109 |
Health Insurance for the Poor |
Universal health coverage; Health financing; Equity and equality |
|
191 |
Bayside 201 |
Universal Health Care |
Universal health care; Equity and equality |
|
192 |
Bayside 202 |
Issues in Hospitals |
Hospital and hospital management; Health care reform; Quality of care |
|
193 |
Bayside 203 |
Issues in Drug Costing |
Pharmaceutical and subtances; Health policy; Economics evaluations and methods |
|
194 |
Bayside 106 |
Utilization |
Cost of care; Quality of care; Service delivery, access and health care utilization; |
|
195 |
Bayside 101 |
Economics of Smoking |
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods |
|
196 |
Bayside Auditorium B |
Hospital Payments |
Hospital and hospital management; Economic evaluations and methods; Quality of care |
|
197 |
Bayside Auditorium A |
Physician Supply |
Health professions; Health policy |
|
198 |
Bayside Terrace |
Economic Burden of Illness |
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods |
|
199 |
Bayside 103 |
Prescribing Behaviour |
Health professions; Pharmeceutical and subtances; Costs of care |
|
200 |
Bayside 104 |
The Impact of Out-of-Pocket Payments |
Economic evaluations and methods; Equity and equality; Health financing |
|
201 |
Bayside 204A |
Effect of Health Expenditure |
Health care financing; Service delivery, access and health care utilization |
|
202 |
Bayside 204B |
Cost of Health Care |
Costs of care |
|
203 |
Bayside 102 |
Issues in Tele-Health |
Health policy; Health reform; Economic evaluations and methods |
|
204 |
Bayside 105 |
Economics of Obesity II |
Non-communicable disease, tobacco and nutrition; Economic evaluation and methods |
|
205 |
Bayside 109 |
Health Care Reform |
Health care refrom |
|
206 |
Bayside 201 |
Improving Hospital Care |
Hospital and hospital management; Quality of care |
|
207 |
Bayside 203 |
Immunization Economics |
Economics evaluation and methods; Service delivery, access, and health care utilization; Non-communicable disease, tobacco, and nutrition |
|
208 |
Bayside 106 |
Policy Intervention |
Cost of care; Health policy |
|
209 |
Bayside 101 |
Treatment Compliance |
Cost of care |
|
210 |
Bayside Auditorium B |
Applications of Willingness-To-Pay |
Patient behavior and behavioral economics; Health providers and patient choice |
|
211 |
Bayside Auditorium A |
Insurance in Developing Markets |
Universal health coverage; Service delivery, access, and health care utilization |
|
212 |
Bayside Terrace |
Taxation Policy |
Economic evaluations and methods |
|
213 |
Bayside 103 |
Early Child Health |
Maternal and child health; Economic evaluations and methods |
|
214 |
Bayside 104 |
Paying Doctors |
Health financing |
|
215 |
Bayside 204A |
Assessing Health Status |
Economic evaluations and methods |
|
216 |
Bayside 204B |
Issues in Out-of-Pocket Payments |
Health financing; Health policy |
|
217 |
Bayside 102 |
Assessing Prevention Programs |
Economic evaluation; Quality of care; Health provider and patient choice |
|
218 |
Bayside 105 |
Subsidizing Insurance |
Service delivery, access and health care utilization; Health providers and patient choice |
|
219 |
Bayside 109 |
What Affects Health II |
Health status impact; Equity and equality |
|
220 |
Bayside 201 |
Economic Evaluation II |
Discrete choice experiments; Economic evaluations and methods |
|
221 |
Bayside 202 |
Health Care Utilization |
Service delivery, access and health care utilization; Maternal and child health |
|
222 |
Bayside 203 |
Public Health Policy |
Health policy; Health reform; Costs of care |
|
223 |
Bayside 106 |
Provider Issues |
Health providers and patient choice; Health professions |
|
224 |
Bayside 101 |
Methodological Issues |
Economic evaluations and methods; Health policy |
|
225 |
TBA |
ePoster Session |
Non-communicable diseases, HIV/AIDS, and vacciness; Economic evaluations and methods; Cost of care; Health professions; Discrete choice experiments; Mental health and elderly health issues; Pharmaceutical and subtances; Health policy |
